GeneMatch: A Program of the Alzheimer's Prevention Registry to Match Individuals to Studies Based on Apolipoprotein E (APOE) Genotype

Alzheimer's Disease Neuroimaging Initiative 3 (ADNI3) Protocol

Phase 2 Study of BIIB092 in Participants With Early Alzheimer's Disease

Alzheimer's Prevention Registry: A Program to Accelerate Enrollment Into Studies

A Study of CAD106 and CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease

Proposal To Develop A Rapid And Cost-Effective Diagnostic Test For Schizophrenia

Effects of Brain Stimulation on Food Intake and Behavioral Weight Loss Treatment

Clinical Evaluation of 18F-AV-1451

Safety and Efficacy Study of Gantenerumab in Participants With Early Alzheimer's Disease (AD)

A Study of LY3303560 in Participants With Early Symptomatic Alzheimer's Disease

Apathy in Dementia Methylphenidate Trial 2

Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type

Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type

A Study of LY3002813 in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ)

A Study of Aducanumab in Participants With Mild Cognitive Impairment Due to Alzheimer's Disease or With Mild Alzheimer's Disease Dementia to Evaluate the Safety of Continued Dosing in Participants With Asymptomatic Amyloid-Related Imaging Abnormalities